Endo, Bayer Defeat Appeal By Custopharm Over Validity Of Patents Related To Testosterone Replacement Therapy Aveed, Says They Admitted To Infringement, Failed To PRove That Endo's And Bayer's Claims Were Invalid
Benzinga Newsdesk